2022
DOI: 10.1016/j.cgh.2021.10.028
|View full text |Cite
|
Sign up to set email alerts
|

A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 32 publications
0
7
0
2
Order By: Relevance
“…62,99 Second, EoE appears to progress to fibrostenosis in many, although not all, patients with EoE, as evidenced by increasing stricture rates with longer symptom duration before diagnosis in adults, longer durations without therapeutic response after diagnosis, and modification of the esophageal transcriptome from inflammatory to epithelial differentiation pathways. 60,86,[100][101][102][103][104][105] Third, because treating the inflammatory component of the disease alone may not adequately alleviate symptoms, it is important to recognize fibrostenosis and consider performing esophageal dilation in symptomatic patients. 106,107 Finally, an ultimate goal should be to diagnose and treat EoE early enough, such that patients neither develop nor progress to fibrostenosis.…”
Section: Meeting Summariesmentioning
confidence: 99%
“…62,99 Second, EoE appears to progress to fibrostenosis in many, although not all, patients with EoE, as evidenced by increasing stricture rates with longer symptom duration before diagnosis in adults, longer durations without therapeutic response after diagnosis, and modification of the esophageal transcriptome from inflammatory to epithelial differentiation pathways. 60,86,[100][101][102][103][104][105] Third, because treating the inflammatory component of the disease alone may not adequately alleviate symptoms, it is important to recognize fibrostenosis and consider performing esophageal dilation in symptomatic patients. 106,107 Finally, an ultimate goal should be to diagnose and treat EoE early enough, such that patients neither develop nor progress to fibrostenosis.…”
Section: Meeting Summariesmentioning
confidence: 99%
“…4). Auch bei Patienten mit bekannter Diagnose, die sich der medizinischen Behandlung entziehen, kann es zu einer Progredienz der Erkrankung kommen [9]. Ein erhöhtes Risiko für Malignome ist nicht bekannt.…”
Section: Verlauf Und Prognoseunclassified
“…Bei Patienten, die sich der medizinischen Behandlung entziehen, kommt es zu einer erneuten Krankheitsprogression und steigender Strikturrate [9]. Umgekehrt führt eine engere Nachsorge (alle 12-18 Monate) zu einer frühzeitigeren Entdeckung eines histologischen Rezidivs und zu einer niedrigeren Strikturrate [19].…”
Section: Monitoringunclassified
“…Delay in EoE diagnosis is also associated with increase in stricture in a time-dependent manner ( 20 ). Moreover, while gaps in clinical care of EoE patients are associated with progression to fibrostenosis ( 21 ), close follow-up is associated with a decrease in stricture in EoE patients ( 22 ). Taken together, these findings support the paradigm that chronic EoE inflammation promotes progression to fibrostenosis ( 15 ).…”
Section: Introductionmentioning
confidence: 99%